Page last updated: 2024-10-30

mesalamine and Psychotic Disorders

mesalamine has been researched along with Psychotic Disorders in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)

Research Excerpts

ExcerptRelevanceReference
"Thalidomide was discontinued and orally administered mesalazine was restarted."1.51Early onset first-episode psychosis during treatment with thalidomide for refractory ulcerative colitis: a case report. ( Ivagnes, S; Margari, F; Margari, L; Palumbi, R; Petruzzelli, MG, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Petruzzelli, MG1
Margari, L1
Ivagnes, S1
Palumbi, R1
Margari, F1

Other Studies

1 other study available for mesalamine and Psychotic Disorders

ArticleYear
Early onset first-episode psychosis during treatment with thalidomide for refractory ulcerative colitis: a case report.
    Journal of medical case reports, 2019, Jun-08, Volume: 13, Issue:1

    Topics: Adolescent; Aftercare; Age of Onset; Anti-Inflammatory Agents, Non-Steroidal; Antipsychotic Agents;

2019